Celgene - 47 Year Dividend Yield History | CELG
Historical dividend payout and yield for Celgene (CELG) since 1971. The current TTM dividend payout for Celgene (CELG) as of December 10, 2018 is $0.00. The current dividend yield for Celgene as of December 10, 2018 is 0.00%.
||Medical - Biomedical and Genetics
Celgene Corporation is a global biopharmaceutical company engaged in the discovery, development and commercialization of innovative therapies for the treatment of cancer and immune-inflammatory related diseases. Their portfolio of commercial products include REVLIMID, VIDAZA, THALOMID, POMALYST/IMNOVID, ABRAXANE, OTEZLA, ISTODAX and IDHIFA. The drug candidates in their pipeline are at various stages of preclinical and clinical development. These candidates include their IMiDs compounds, which are a proprietary class of compounds that have certain immunomodulatory and other biologically important properties in addition to their leading oral anti-inflammatory agents and cellular therapies. They believe their commercial stage products and the depth of their product pipeline, provide the catalysts for future growth.